PRA Health Sciences, Inc. (PRAH) financial statements (2021 and earlier)

Company profile

Business Address 4130 PARKLAKE AVENUE
RALEIGH, NC 27612
State of Incorp. DE
Fiscal Year End December 31
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments506236144192145121
Cash and cash equivalents506236144192145121
Restricted cash and investments 00155
Receivables844659568627439415
Other undisclosed current assets1109170573633
Total current assets:1,461986782877625574
Noncurrent Assets
Operating lease, right-of-use asset178186
Property, plant and equipment1951811551438881
Long-term investments and receivables   001
Long-term investments   001
Intangible assets, net (including goodwill)2,2912,1412,1992,2961,4461,549
Goodwill1,6911,5031,4951,5129721,015
Intangible assets, net (excluding goodwill)600639704784474534
Deferred costs    22
Deferred income tax assets1510
Other noncurrent assets373740312419
Deferred tax assets, net  73
Other undisclosed noncurrent assets331011  
Total noncurrent assets:2,7182,5592,4042,4811,5661,655
TOTAL ASSETS:4,1793,5443,1863,3582,1902,229
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities212181225207167160
Accounts payable575544655157
Employee-related liabilities1501191341268678
Taxes payable3244142619
Interest and dividends payable253346
Deferred revenue733506
Debt2563 2931 
Business combination, contingent consideration, liability  83   
Deferred revenue and credits469333334
Contract with customer, liability441
Other liabilities434543453436
Other undisclosed current liabilities253223107222  
Total current liabilities:1,2661,017899972564530
Noncurrent Liabilities
Long-term debt and lease obligation1,3181,3131,0821,225797890
Long-term debt, excluding current maturities1,1591,1401,0821,225797890
Operating lease, liability159172
Liabilities, other than long-term debt11612553112100107
Deferred tax liabilities, net  7482
Deferred income tax liabilities6379
Other liabilities5246531122625
Other undisclosed noncurrent liabilities  101112  
Total noncurrent liabilities:1,4331,4371,2361,450897996
Total liabilities:2,6992,4542,1352,4221,4611,526
Stockholders' equity
Stockholders' equity attributable to parent1,4791,0901,045931729703
Common stock111111
Additional paid in capital1,1371,006961905879828
Accumulated other comprehensive loss(99)(160)(171)(136)(225)(132)
Retained earnings440243255161746
Stockholders' equity attributable to noncontrolling interest  66  
Total stockholders' equity:1,4791,0901,051936729703
TOTAL LIABILITIES AND EQUITY:4,1793,5443,1863,3582,1902,229

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues3,1833,0662,8722,2591,8121,614
Revenue, net2,2591,8121,614
Cost of revenue
(Cost of Goods and Services Sold)
   (1,595)(1,264)(1,125)
Gross profit:3,1833,0662,872665547489
Operating expenses(453)(396)(372)(322)(271)(247)
Other undisclosed operating loss(2,402)(2,306)(2,219)(166)(114)(78)
Operating income:328364281176162164
Nonoperating income (expense)(26)(2)(1)(40)2513
Foreign currency transaction gain (loss), before tax(25)(2)(1)(40)2414
Other nonoperating income (expense)(0)0(0)(0)1(1)
Interest and debt expense(0)(1)(1)(15)(38) 
Other undisclosed loss from continuing operations before equity method investments, income taxes(43)(55)(57)(47)(55)(62)
Income from continuing operations before equity method investments, income taxes:2593062227594115
Income (loss) from equity method investments  003(3)
Income from continuing operations before income taxes:2593062227597112
Income tax expense (benefit)(62)(63)(67)13(28)(30)
Net income:197243154876882
Net loss attributable to noncontrolling interest (0)(1)(0)  
Net income attributable to parent:197243154876882
Other undisclosed net income available to common stockholders, basic   0  
Net income available to common stockholders, diluted:197243154876882

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income:197243154876882
Other comprehensive income (loss)619(34)88(92)(63)
Comprehensive income (loss):258252120175(24)19
Comprehensive loss, net of tax, attributable to noncontrolling interest (0)(1)(0)  
Comprehensive income (loss), net of tax, attributable to parent:258252120175(24)19

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: